Ayoub, M.; Chela, H.; Amin, N.; Hunter, R.; Anwar, J.; Tahan, V.; Daglilar, E.
Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis. J. Clin. Med. 2025, 14, 944.
https://doi.org/10.3390/jcm14030944
AMA Style
Ayoub M, Chela H, Amin N, Hunter R, Anwar J, Tahan V, Daglilar E.
Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis. Journal of Clinical Medicine. 2025; 14(3):944.
https://doi.org/10.3390/jcm14030944
Chicago/Turabian Style
Ayoub, Mark, Harleen Chela, Nisar Amin, Roberta Hunter, Javaria Anwar, Veysel Tahan, and Ebubekir Daglilar.
2025. "Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis" Journal of Clinical Medicine 14, no. 3: 944.
https://doi.org/10.3390/jcm14030944
APA Style
Ayoub, M., Chela, H., Amin, N., Hunter, R., Anwar, J., Tahan, V., & Daglilar, E.
(2025). Pancreatitis Risk Associated with GLP-1 Receptor Agonists, Considered as a Single Class, in a Comorbidity-Free Subgroup of Type 2 Diabetes Patients in the United States: A Propensity Score-Matched Analysis. Journal of Clinical Medicine, 14(3), 944.
https://doi.org/10.3390/jcm14030944
